Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Durham, North Carolina
- Most recent report
- 8-K, filed Sep 9, 2026
- Incorporated
- Delaware
- Filings on record
- 1,011+ filings
- On EDGAR
- CIK 1228627
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer, Smaller reporting company
Financials 8 of 77
News 8 of 219
- 8-K Other events Sep 9, 2026
- 8-K Quarterly results Aug 6, 2026
- 8-K Current report on a material event Jun 16, 2026
- 8-K Current report on a material event Jun 16, 2026
- 8-K Quarterly results May 12, 2026
- 8-K Current report on a material event Apr 24, 2026
- 8-K Shareholder vote results Apr 22, 2026
- 8-K Leadership change Apr 7, 2026
Prospectuses and Registrations 8 of 72
- S-3 Shelf registration statement Aug 7, 2026
- 424B2 Prospectus supplement for an offering Jun 17, 2026
- S-3 Shelf registration statement Jun 5, 2026
- S-8 Registration statement for an employee plan May 14, 2026
- S-3/A Shelf registration statement, amended Apr 21, 2026
- S-3 Shelf registration statement Mar 13, 2026
- S-8 Registration statement for an employee plan Jan 22, 2026
- FWP Free writing prospectus Nov 6, 2025
Proxies 8 of 50
- DEF 14A Proxy statement for a shareholder vote Mar 23, 2026
- PRE 14A Preliminary proxy statement Mar 12, 2026
- DEFA14A Extra proxy material Apr 14, 2025
- PX14A6G Shareholder's own proxy material Apr 11, 2025
- DEFA14A Extra proxy material Apr 11, 2025
- DEFA14A Extra proxy material Apr 10, 2025
- DEFA14A Extra proxy material Apr 7, 2025
- DEFR14A May 30, 2024
Ownership 8 of 469
- 4 Insider reported a trade Sep 8, 2026
- 4 Insider reported a trade Sep 8, 2026
- 144 Notice of a proposed sale of restricted stock Sep 3, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- 4 Insider reported a trade Jul 27, 2026
- 4 Insider reported a trade Jul 27, 2026
Other 8 of 124
- EFFECT Notice that a registration became effective Aug 14, 2026
- EFFECT Notice that a registration became effective Jun 15, 2026
- EFFECT Notice that a registration became effective Apr 22, 2026
- CORRESP Reply to SEC staff Apr 21, 2026
- ARS Annual report sent to shareholders Mar 23, 2026
- UPLOAD Comment letter from SEC staff Mar 17, 2026
- EFFECT Notice that a registration became effective Apr 10, 2025
- DFAN14A Apr 9, 2025
Everything here comes from Opus Genetics, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.